Endast för hälso-och sjukvårdspersonal
How can we improve outcomes for patients with R/R LBCL?
Interview: 6 minutes
Listen to Professor Mats Jerkeman from Skåne University Hospital in Lund, Sweden, as he discusses the treatment gap in R/R LBCL, which patients are suitable for CAR-T, the expected benefits, and the side effect profile associated with CAR-T therapy.
Related videos
Optimizing CAR-T Bridging Therapy in LBCL
Post-CAR-T treatment and outpatient setting
News
Learn about current topics in hematology, such as new research data, news from events, congresses and more.
Education
Find past and upcoming educational events and access learning tools such as webinars, training videos and expert interviews.
HE-SE-2500010 FEB25 video/ 2009-SE-2500035 01/2026